Assignee
CLEVELAND BIOLABS INC
US·8 granted patents·8 pending applications·43 citations·filing 2006–2020
Top patents by PatentIndex Score
16 records- 0196US7638485B2Modulating apoptosisCLEVELAND BIOLABS INC·Filed 2006·Granted Dec 29, 2009·29 cites·13 claims
- 0292US10034926B2Use of toll-like receptor agonist for treating cancerCLEVELAND BIOLABS INC·Filed 2017·Granted Jul 31, 2018·5 cites·19 claims
- 0390US9006180B2Methods for treating tourniquet-induced injuriesCLEVELAND BIOLABS INC·Filed 2013·Granted Apr 14, 2015·5 cites·13 claims
- 0483US10183056B2Methods and compositions for the treatment of radiation-related disordersCLEVELAND BIOLABS INC·Filed 2015·Granted Jan 22, 2019·3 cites·13 claims
- 0582US10857200B2Methods and compositions for the treatment of radiation-related disordersCLEVELAND BIOLABS INC·Filed 2018·Granted Dec 8, 2020·1 cites·13 claims
- 0675US10780152B2Use of toll-like receptor agonist for treating cancerCLEVELAND BIOLABS INC·Filed 2019·Granted Sep 22, 2020·0 cites·19 claims
- 0773US11628201B2Use of toll-like receptor agonist for treating cancerCLEVELAND BIOLABS INC·Filed 2020·Granted Apr 18, 2023·0 cites·19 claims
- 0872US10265390B2Use of toll-like receptor agonist for treating cancerCLEVELAND BIOLABS INC·Filed 2018·Granted Apr 23, 2019·0 cites·19 claims
- 0968US2018354995A1Flagellin-based agents and uses including effective vaccinationCLEVELAND BIOLABS INC·Filed 2018·Application pending·0 cites
- 1066US2021275627A1Methods and compositions for the treatment of radiation-related disordersCLEVELAND BIOLABS INC·Filed 2020·Application pending·0 cites
- 1165US2017065692A1Use of toll-like receptor agonist for treating cancerCLEVELAND BIOLABS INC·Filed 2016·Application pending·0 cites
- 1263US2016206690A1Use of toll-like receptor agonist for treating cancerCLEVELAND BIOLABS INC·Filed 2015·Application pending·0 cites
- 1360US2015182587A1Methods for treating reperfusion injuriesCLEVELAND BIOLABS INC·Filed 2015·Application pending·0 cites
- 1459US2014045747A1Methods for increasing and mobilizing hematopoietic stem cellsCLEVELAND BIOLABS INC·Filed 2013·Application pending·0 cites
- 1551US2015174195A1Methods for increasing and mobilizing hematopoietic stem cellsCLEVELAND BIOLABS INC·Filed 2015·Application pending·0 cites
- 1649US2015328284A1Compositions and methods comprising toll like receptor (tlr) stimulating agents for prophylaxis and therapy for damage to dermal epitheliumCLEVELAND BIOLABS INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CLEVELAND BIOLABS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →